Save the New Antibiotic Cefiderocol for Salvage Therapy

Cefiderocol (Fetroja, fet-ROH-jah) will be a new IV cephalosporin for multidrug-resistant (MDR) gram-negative infections.

It doesn’t fall into a cephalosporin “generation.” But think of it like ceftazidime or cefepime with an extended side chain.

This gives cefiderocol broad in vitro coverage for many types of carbapenem-resistant Enterobacteriaceae (CRE)...and resistant Pseudomonas, Acinetobacter, and Stenotrophomonas.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote